Alternative therapies are mentioned often by participants in the workers compensation sector trying to manage injured workers' pain while shifting away from the industry's dependence on opioids — and acupuncture is the talk of the town.
Alternative therapies are mentioned often by participants in the workers compensation sector trying to manage injured workers' pain while shifting away from the industry's dependence on opioids — and acupuncture is the talk of the town.
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
The Indiana legislature passed a drug formulary bill based on ODG Guidelines.
The repair network of today is not your grandfather’s or your father’s repair network; in fact it may not even be your older brother’s repair network. Vehicles are becoming more sophisticated with every new model that rolls off the production line. They’re no longer merely a mode of transportation—they’re complex computer networks on wheels.
Interest in drug formularies has grown significantly in the past few years, coinciding with a greater concern over the opioid crisis. Texas and Ohio were pioneering states in the creation of drug formularies and several states have followed suit recently. Oklahoma, Washington, Ohio, Tennessee, California, Arizona and Texas all have statewide drug formularies; states including Massachusetts, Indiana, Pennsylvania and New York are currently considering or developing formularies.
As technology evolves, several key ideas continue to permeate our conversations. One of the most exciting topics in 2018 is the application of predictive analytics in insurance and claims handling in particular. Unlike many of the broader terms in the industry (i.e. artificial intelligence, big data and InsureTech), predictive analytics has specific and practical workflow applications today and continues to be an industry game changer.
From high praise to a spiraling crash, opioid-based pain medications are out of favor.